Reported 0 shares, down 172,640 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 308000 |
| 2021-12-31 | 150000 |
| 2022-03-31 | 121000 |
| 2022-06-30 | 74000 |
| 2022-09-30 | 68000 |
| 2022-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2022 | Reduced | 0 | -172,640 (-100.0%) | 0 | $0 | 2023-02-14 | |
| Q3 2022 | Added | 172,640 | +42,200 (32.4%) | < 0.01% | $68,000 | 2022-11-15 | |
| Q2 2022 | Added | 130,440 | +22,600 (21.0%) | < 0.01% | $74,000 | 2022-08-15 | |
| Q1 2022 | Added | 107,840 | +5,100 (5.0%) | < 0.01% | $121,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 102,740 | 0 (0.0%) | < 0.01% | $150,000 | 2022-02-14 | |
| Q3 2021 | Unchanged | 102,740 | 0 (0.0%) | < 0.01% | $308,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
66 managers reported UNITY BIOTECHNOLOGY INC for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Mayo Clinic | Unchanged | 157,198 | 0 | 0.23% | $430,723 | 1 qtr |
| Rosenberg Matthew Hamilton | New | 200 | +200 | < 0.01% | $548 | 1 qtr |
| VICTORY CAPITAL MANAGEMENT INC | Reduced | 0 | -14,010 | 0 | $0 | 2 qtrs |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | 0 | -74 | 0 | $0 | 18 qtrs |
| Laurion Capital Management LP | Reduced | 0 | -700,000 | 0 | $0 | 2 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 0 | -22,620 | 0 | $0 | 19 qtrs |
| TRUE Private Wealth Advisors | Reduced | 0 | -15,740 | 0 | $0 | 4 qtrs |
| Virtu Financial LLC | Reduced | 0 | -35,098 | 0 | $0 | 5 qtrs |
| ROYAL BANK OF CANADA | Reduced | 0 | -1,663 | 0 | $0 | 19 qtrs |
| BlackRock Inc | Reduced | 0 | -563,488 | 0 | $0 | 19 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- February 14, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.